Fig. 2

Comparison of bone turnover markers levels between r-axSpA with and without fatty lesions. The serum levels of sclerostin were significantly lower in r-axSpA patients with fatty lesions than in those without fatty lesions (p < 0.001). No significant differences were observed in terms of OPG, PINP, CTX-I or OC between two groups